DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Wen PY, Reardon DA, Phuphanich S. et al.
A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.
J Clin Oncol 2014;
32: abstr 2005
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.